Inscobee Inc.

Insider Reports History

Location
Room 613, Digital Ro 130, 6 F, Geumcheon Gu, Seoul, Korea, Republic of
Signature
/s/ Nelson Mullins Riley & Scarborough LLP, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Inscobee Inc.:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Apimeds Pharmaceuticals US, Inc. 10%+ Owner Common Stock, par value $0.0001 per share 4.32M $8.81M $2.04 May 12, 2024 By Apimeds Inc.
Apimeds Pharmaceuticals US, Inc. 10%+ Owner Convertible Promissory Note 0 May 12, 2025 By Apimeds Inc.
Apimeds Pharmaceuticals US, Inc. 10%+ Owner Convertible Promissory Note 0 May 12, 2025 Direct

Insider Reports Filed by Inscobee Inc.

Symbol Company Period Transactions Value $ Form Type Date Filed Role
APUS Apimeds Pharmaceuticals US, Inc. May 12, 2025 4 $599K 4/A Jun 11, 2025 10%+ Owner
APUS Apimeds Pharmaceuticals US, Inc. Mar 4, 2025 0 $0 3/A Jun 11, 2025 10%+ Owner
APUS Apimeds Pharmaceuticals US, Inc. Mar 4, 2025 0 $0 3/A May 14, 2025 10%+ Owner
APUS Apimeds Pharmaceuticals US, Inc. May 12, 2024 0 $0 4/A Nov 21, 2025 10%+ Owner